-
1
-
-
0031938089
-
Pharmacological actions of sulodexide
-
Ofosu FA: Pharmacological actions of sulodexide. Semin Thromb Hemost 1998;24:127-138.
-
(1998)
Semin Thromb Hemost
, vol.24
, pp. 127-138
-
-
Ofosu, F.A.1
-
2
-
-
0026447391
-
Sulodexide oral administration influences blood viscosity and fibrinolysis
-
Crepaldi G, Rossi A, Coscetti G, et al: Sulodexide oral administration influences blood viscosity and fibrinolysis. Drugs Exp Clin Res 1992;18:189-195.
-
(1992)
Drugs Exp Clin Res
, vol.18
, pp. 189-195
-
-
Crepaldi, G.1
Rossi, A.2
Coscetti, G.3
-
3
-
-
0025264190
-
Double-blind trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use
-
Crepaldi G, Fellin R, Calabro A, et al: Double-blind trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use. Atherosclerosis 1990;81:233-243.
-
(1990)
Atherosclerosis
, vol.81
, pp. 233-243
-
-
Crepaldi, G.1
Fellin, R.2
Calabro, A.3
-
4
-
-
0021917821
-
The effectiveness of glycosaminoglycans in peripheral vascular disease therapy: A clinical and experimental trial
-
Corsi C, Bocci L, Cipriani C, et al: The effectiveness of glycosaminoglycans in peripheral vascular disease therapy: a clinical and experimental trial. J Int Med Res 1985;13:40-47.
-
(1985)
J Int Med Res
, vol.13
, pp. 40-47
-
-
Corsi, C.1
Bocci, L.2
Cipriani, C.3
-
5
-
-
33644878779
-
Carotid plaque reduction after medical treatment
-
Stivali G, Cerroni F, Bianco P, et al: Carotid plaque reduction after medical treatment. Circulation 2005;112:e276-e277.
-
(2005)
Circulation
, vol.112
-
-
Stivali, G.1
Cerroni, F.2
Bianco, P.3
-
6
-
-
13244253793
-
Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis
-
Lauver DA, Booth EA, White AJ, et al: Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharmacol Exp Ther 2005;312:794-800.
-
(2005)
J Pharmacol Exp Ther
, vol.312
, pp. 794-800
-
-
Lauver, D.A.1
Booth, E.A.2
White, A.J.3
-
7
-
-
33646455615
-
In vivo antithrombotic synergy of oral heparin and arginine: Endothelial thromboresistance without changes in coagulation parameters
-
Daniels B, Linhardt RJ, Zhang F, et al: In vivo antithrombotic synergy of oral heparin and arginine: endothelial thromboresistance without changes in coagulation parameters. Thromb Haemost 2006;95:865-872.
-
(2006)
Thromb Haemost
, vol.95
, pp. 865-872
-
-
Daniels, B.1
Linhardt, R.J.2
Zhang, F.3
-
8
-
-
0026659040
-
Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats
-
Gambaro G, Cavazzana AO, Luzi P, et al: Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 1992;29:285-291.
-
(1992)
Kidney Int
, vol.29
, pp. 285-291
-
-
Gambaro, G.1
Cavazzana, A.O.2
Luzi, P.3
-
9
-
-
29244469623
-
One year of oral sulodexide in the management of diabetic nephropathy
-
Achour A, Kacem M, Dibej K, et al: One year of oral sulodexide in the management of diabetic nephropathy. J Nephrol 2005;18:568-574.
-
(2005)
J Nephrol
, vol.18
, pp. 568-574
-
-
Achour, A.1
Kacem, M.2
Dibej, K.3
-
10
-
-
33746691250
-
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy
-
Abaterusso C, Gambaro G: The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. Treat Endocrinol 2006;5:211-222.
-
(2006)
Treat Endocrinol
, vol.5
, pp. 211-222
-
-
Abaterusso, C.1
Gambaro, G.2
-
11
-
-
0032918585
-
Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis
-
Fracasso A, Baggio B, Ossi E, et al: Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis. Am J Kidney Dis 1999;33:105-110.
-
(1999)
Am J Kidney Dis
, vol.33
, pp. 105-110
-
-
Fracasso, A.1
Baggio, B.2
Ossi, E.3
-
12
-
-
0029148402
-
Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis
-
Bazzato G, Fracasso A, Gambaro G, Baggio B: Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis. Lancet 1995;346:740-741.
-
(1995)
Lancet
, vol.346
, pp. 740-741
-
-
Bazzato, G.1
Fracasso, A.2
Gambaro, G.3
Baggio, B.4
-
13
-
-
0348044485
-
Effect of oral treatment with the glycosaminoglycan sulodexide on peritoneal transport in CAPD patients
-
Fracasso A, Baggio B, Masiero M, et al: Effect of oral treatment with the glycosaminoglycan sulodexide on peritoneal transport in CAPD patients. Perit Dial Int 2003;23:595-599.
-
(2003)
Perit Dial Int
, vol.23
, pp. 595-599
-
-
Fracasso, A.1
Baggio, B.2
Masiero, M.3
-
14
-
-
0027499988
-
Suppressive effects of hyaluronic acid on elastase release from rat peritoneal leukocytes
-
Akatsuka M, Yamamoto Y, Tobetto K, et al: Suppressive effects of hyaluronic acid on elastase release from rat peritoneal leukocytes. J Pharm Pharmacol 1993;45:110-114.
-
(1993)
J Pharm Pharmacol
, vol.45
, pp. 110-114
-
-
Akatsuka, M.1
Yamamoto, Y.2
Tobetto, K.3
-
15
-
-
0036413438
-
The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter
-
Pecoits-Filho R, Lindholm B, Stenvinkel P: The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 2002;17(suppl 11):28-31.
-
(2002)
Nephrol Dial Transplant
, vol.17
, Issue.SUPPL. 11
, pp. 28-31
-
-
Pecoits-Filho, R.1
Lindholm, B.2
Stenvinkel, P.3
-
16
-
-
33745544967
-
Malnutrition-inflammation- atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients
-
Tonbul HZ, Demir M, Altintepe L, et al: Malnutrition-inflammation- atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail 2006;28:287-294.
-
(2006)
Ren Fail
, vol.28
, pp. 287-294
-
-
Tonbul, H.Z.1
Demir, M.2
Altintepe, L.3
-
17
-
-
0028365467
-
Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats
-
Brȩborowicz A, Wieczorowska K, Martis L, Oreopoulos DG: Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats. Nephron 1994;67:346-350.
-
(1994)
Nephron
, vol.67
, pp. 346-350
-
-
Brȩborowicz, A.1
Wieczorowska, K.2
Martis, L.3
Oreopoulos, D.G.4
-
18
-
-
0006360236
-
Dialysis solution containing hyaluronan: Effect on peritoneal permeability and inflammation in rats
-
Połubinska A, Pawlaczyk K, Kuzlan-Pawlaczyk M, et al: Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats. Kidney Int 2000;57:1182-1189.
-
(2000)
Kidney Int
, vol.57
, pp. 1182-1189
-
-
Połubinska, A.1
Pawlaczyk, K.2
Kuzlan-Pawlaczyk, M.3
-
19
-
-
0035571598
-
Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid - experimental study in rats
-
Brȩborowicz A, Pawlaczyk-Kuzlan M, Pawlaczyk K, et al: Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid - experimental study in rats. Perit Dial Int 2001;21(suppl 3):s316-s318.
-
(2001)
Perit Dial Int
, vol.21
, Issue.SUPPL. 3
-
-
Brȩborowicz, A.1
Pawlaczyk-Kuzlan, M.2
Pawlaczyk, K.3
-
20
-
-
21344463080
-
Intraperitoneal heparin ameliorates the systemic inflammatory response in peritoneal dialysis patients
-
Sjoland JA, Pedersen RS, Jespersen J, Gram J: Intraperitoneal heparin ameliorates the systemic inflammatory response in peritoneal dialysis patients. Nephron Clin Pract 2005;100:c105-c110.
-
(2005)
Nephron Clin Pract
, vol.100
-
-
Sjoland, J.A.1
Pedersen, R.S.2
Jespersen, J.3
Gram, J.4
-
21
-
-
0035123653
-
Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats
-
Brȩborowicz A, Połubinska A, Moberly J, et al: Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats. Am J Kidney Dis 2001;37:594-600.
-
(2001)
Am J Kidney Dis
, vol.37
, pp. 594-600
-
-
Brȩborowicz, A.1
Połubinska, A.2
Moberly, J.3
-
22
-
-
0036257599
-
Macrophages and the pathogenesis of COPD
-
Tetley TD: Macrophages and the pathogenesis of COPD. Chest 2002;121(suppl):156S-159S.
-
(2002)
Chest
, vol.121
, Issue.SUPPL.
-
-
Tetley, T.D.1
|